School of Pharmacy

Prof Needham has submitted a patent application on a new anti-COVID nasal spray


Professor David Needham has submitted a patent application on a new anti-COVID nasal spray and a paper published in Pharmaceutical Research.The patent - Niclosamide nasal and throat spray: The present disclosure provides prophylactic pH-buffered solution of niclosamide that can be used as a nasal and throat spray to prevent initial infection of COVID19, its more contagious variants, and other respiratory viral infections. It also provides a method of making such solution that does not require excess niclosamide to be dissolved in aqueous media. Furthermore, it describes a method for extracting niclosamide from commercially available tablets into aqueous solution that does not involve the use of organic solvents. David NeedhamThe pH dependence of niclosamide solubility, dissolution, and morphology: Motivation for potentially universal mucin-penetrating nasal and throat sprays for COVID19, its variants and other viral infectionsPharmaceutical Research, 2021. DOI: 10.1007/s11095-021-03112-x

Posted on Wednesday 19th January 2022

School of Pharmacy

University of Nottingham
University Park
Nottingham, NG7 2RD

For all enquiries please visit: